Minnesota manager Derek Shelton got himself ejected in the ninth inning against Baltimore over a pitch review.

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...

The trial enrolled just half of its planned patients, leaving spironolactone’s role in HFpEF and HFmrEF still up in the air.

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...

A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study ...

Background The Heart Failure Association Pre-test Assessment, Echocardiography and Natriuretic Peptide, Functional testing, ...

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet VERQUVO was ...

NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...

MADRID -- Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.

MADRID, Spain—Two randomized, controlled trials testing beta-blockers in post-MI patients without heart failure or impaired left ventricular ejection fraction added a bit of confusion to a field ...

The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...